Skip to content
OpenCapital
Get started

Aardvark Therapeutics, Inc. Common Stock AARD Q3 2025 earnings

Reported November 13, 2025 · Before market open

Revenue-Diluted EPS-$0.75Beat by $0.05
EPS estimate-$0.80

Next report

Aug 12, 2026 (in a month)
EPS estimate-$0.86

Financials

Q3 2025

Income statement

See full
Revenue-—
Operating income-$17.7M-248%
Net income-$16.3M-290%
EPS (diluted)-$0.75+28.6%

Balance sheet

See full
Cash & equivalents$39.3M—
Total debt$545.0K—
Total equity$122.4M+365%
Total assets$133.2M—

Cash flow

See full
Operating cash flow-$16.1M-308%
CapEx$4.0K-20.0%
Free cash flow-$16.1M-307%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$288.3M—
Enterprise value$249.56M—

Returns & leverage

See full
Debt / equity0×—
Current ratio12×—

Versus estimates

Diluted EPS

Q1 2026-$0.99Miss by $0.12Q4 2025-$0.81Beat by $0.02
Q3 2025-$0.75Beat by $0.05
Q2 2025-$0.66Miss by $0.06Q1 2025-$0.71Miss by $0.04Q4 2024-$0.68Miss by $0.27

Ask the moment Aardvark Therapeutics, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Aardvark Therapeutics, Inc. Common Stock report Q3 2025 earnings?
Aardvark Therapeutics, Inc. Common Stock (AARD) reported Q3 2025 earnings on November 13, 2025 before market open.
What were Aardvark Therapeutics, Inc. Common Stock's Q3 2025 revenue and EPS?
Aardvark Therapeutics, Inc. Common Stock reported revenue of - and diluted EPS of $-0.75 for Q3 2025.
Did Aardvark Therapeutics, Inc. Common Stock beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.80 by $0.05.
How did Aardvark Therapeutics, Inc. Common Stock's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 131.5% from $-0.32.
Where can I find Aardvark Therapeutics, Inc. Common Stock's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-280235) and the 10-Q periodic report (0001193125-25-280260) directly on SEC EDGAR. The filing index links above go to sec.gov.